Oral dydrogesterone along with vaginal micronized progesterone supplementation for luteal phase support in IVF patients, and its impact on pregnancy and live birth rates: a prospective randomized trial
Leonardo Rinaldi, Francesco Crescenzi, Helmy Selman
Springer Nature ·
2024-12-21
· DOI 10.1186/s12884-024-07069-8
The publisher did not provide an abstract — full text is available via the link below.
Leonardo Rinaldi, Francesco Crescenzi, Helmy Selman. Oral dydrogesterone along with vaginal micronized progesterone supplementation for luteal phase support in IVF patients, and its impact on pregnancy and live birth rates: a prospective randomized trial. // BMC Pregnancy and Childbirth. – 2024. – DOI: 10.1186/s12884-024-07069-8. – URL: https://doi.org/10.1186/s12884-024-07069-8
Leonardo Rinaldi, Francesco Crescenzi, & Helmy Selman (2024). Oral dydrogesterone along with vaginal micronized progesterone supplementation for luteal phase support in IVF patients, and its impact on pregnancy and live birth rates: a prospective randomized trial. BMC Pregnancy and Childbirth. https://doi.org/10.1186/s12884-024-07069-8
Leonardo Rinaldi, et al. “Oral dydrogesterone along with vaginal micronized progesterone supplementation for luteal phase support in IVF patients, and its impact on pregnancy and live birth rates: a prospective randomized trial.” BMC Pregnancy and Childbirth, 2024. doi:10.1186/s12884-024-07069-8.
@article{Rinaldi2024,
title = {Oral dydrogesterone along with vaginal micronized progesterone supplementation for luteal phase support in IVF patients, and its impact on pregnancy and live birth rates: a prospective randomized trial},
author = {Rinaldi, Leonardo and Crescenzi, Francesco and Selman, Helmy},
journal = {BMC Pregnancy and Childbirth},
year = {2024},
doi = {10.1186/s12884-024-07069-8},
url = {https://doi.org/10.1186/s12884-024-07069-8}
}